Wedbush initiated coverage of Solid Biosciences (SLDB) with an Outperform rating and $16 price target
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLDB:
- Solid Biosciences initiated with an Outperform at JMP Securities
- Solid Biosciences management to meet with Piper Sandler
- Solid Biosciences announces collaboration with Mayo Clinic
- Solid Biosciences reports inducement grant under Nasdaq listing rule
- Solid Biosciences Reports Increased Losses Amid R&D Focus